Vicore Pharma Holding AB (publ) (VCRE)
NCM · Healthcare · Biotechnology
$10.32
+11.21%
Closing price as of 2026-10-22 · Source: TEK2day Finance
Key Metrics
Market Cap
$290.7M
Shares Outstanding
28.2M
Exchange
NCM
Currency
USD
Quarterly Financials
| Metric | 2025-09-30 | 2025-12-31 | 2026-03-31 | 2026-06-30 |
|---|---|---|---|---|
| Revenue | 419K | 602K | 2.2M | |
| Gross Profit | 419K | 602K | 2.2M | |
| Operating Income | (133.7M) | (123.8M) | (150.1M) | |
| Net Income | (137.1M) | (108.6M) | (142.8M) | |
| Diluted EPS | $-4.80 | $-5.40 | $-3.90 | $-5.10 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 109.3M | 3.8M |
| Gross Profit | 0.00 | 0.00 | 109.3M | 3.8M |
| Operating Income | (287.5M) | (320.9M) | (190.4M) | (454.4M) |
| Net Income | (288.4M) | (310.9M) | (168.6M) | (477.5M) |
| Diluted EPS | $-38.82 | $-31.80 | $-12.30 | $-19.90 |